MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test
Test Name: MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MGAT2 Gene Glycosylation Disorder Type 2A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MGAT2 Gene Glycosylation Disorder Type 2A.
Test Details
The MGAT2 gene encodes for an enzyme that is involved in the process of glycosylation, which is the addition of sugar molecules to proteins. Glycosylation is important for the proper functioning of many proteins in the body, including those involved in cell signaling, immune system function, and tissue development.
Mutations in the MGAT2 gene can lead to a rare genetic disorder known as glycosylation disorder type 2A (also called MGAT2-CDG). This disorder is characterized by a range of symptoms that can vary in severity, including developmental delays, intellectual disability, seizures, abnormal facial features, and other physical abnormalities.
NGS (next-generation sequencing) genetic testing can be used to identify mutations in the MGAT2 gene that may be causing glycosylation disorder type 2A. This type of testing uses advanced DNA sequencing technology to analyze multiple genes at once, allowing for a more comprehensive analysis of a patient’s genetic information.
NGS genetic testing for glycosylation disorder type 2A can help to confirm a diagnosis, guide treatment decisions, and provide important information for genetic counseling. It may also be used to identify other family members who may be at risk for the disorder.
| Test Name | MGAT2 Gene Glycosylation disorde type 2A Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MGAT2 Gene Glycosylation disorde type 2A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MGAT2 Gene Glycosylation disorde type 2A |
| Test Details | MGAT2 gene encodes for an enzyme that is involved in the process of glycosylation, which is the addition of sugar molecules to proteins. Glycosylation is important for the proper functioning of many proteins in the body, including those involved in cell signaling, immune system function, and tissue development. Mutations in the MGAT2 gene can lead to a rare genetic disorder known as glycosylation disorder type 2A (also called MGAT2-CDG). This disorder is characterized by a range of symptoms that can vary in severity, including developmental delays, intellectual disability, seizures, abnormal facial features, and other physical abnormalities. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the MGAT2 gene that may be causing glycosylation disorder type 2A. This type of testing uses advanced DNA sequencing technology to analyze multiple genes at once, allowing for a more comprehensive analysis of a patient’s genetic information. NGS genetic testing for glycosylation disorder type 2A can help to confirm a diagnosis, guide treatment decisions, and provide important information for genetic counseling. It may also be used to identify other family members who may be at risk for the disorder. |
